These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6233248)

  • 1. Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance.
    Greenwood D; Osman M; Goodwin J; Cowlishaw WA; Slack R
    J Antimicrob Chemother; 1984 Apr; 13(4):315-23. PubMed ID: 6233248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.
    Teoh-Chan CH; Cowlishaw A; Eley A; Slater G; Greenwood D
    J Antimicrob Chemother; 1985 Jan; 15(1):45-52. PubMed ID: 3156113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effect of pH and glucose concentration on the antibacterial activity of norfloxacin in urine.
    Fromtling RA; Abruzzo GK; Gadebusch HH
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):737-41. PubMed ID: 6241649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norfloxacin: in vitro activity compared with that of seven other antibacterial agents against urinary tract pathogens.
    Digranes A; Dibb WL; Ostervold B
    Acta Pathol Microbiol Immunol Scand B; 1984 Apr; 92(2):101-6. PubMed ID: 6233841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance.
    Corigliano BE; Appleman MD; Heseltine PN; Leedom JM
    Diagn Microbiol Infect Dis; 1984 Apr; 2(2):101-6. PubMed ID: 6232085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.
    Downs J; Andriole VT; Ryan JL
    Antimicrob Agents Chemother; 1982 Apr; 21(4):670-2. PubMed ID: 6211142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in-vitro activity of norfloxacin and selected antimicrobial agents against urinary tract pathogens and Neisseria gonorrhoeae.
    Sweet RL; Ohm-Smith MJ; Hadley WK
    J Antimicrob Chemother; 1982 Dec; 10(6):553-7. PubMed ID: 6219085
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifampicin plus nalidixic acid: a rational combination for the treatment of urinary infection.
    Greenwood D; Andrew J
    J Antimicrob Chemother; 1978 Nov; 4(6):533-8. PubMed ID: 101503
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibacterial efficacy of norfloxacin, trimethoprim-sulfamethoxazole, and gentamicin in experimentally-infected normal and streptozotocin-induced diabetic mice.
    Fromtling RA; Abruzzo GK; Gadebusch HH
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):731-5. PubMed ID: 6241648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose.
    Hofbauer H; Naber KG; Kinzig-Schippers M; Sörgel F; Rustige-Wiedemann C; Wiedemann B; Reiz A; Kresken M
    Infection; 1997; 25(2):121-6. PubMed ID: 9108190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottnad-Walz M; Stille W
    Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates.
    Khan MY; Gruninger RP; Nelson SM; Klicker RE
    Antimicrob Agents Chemother; 1982 May; 21(5):848-51. PubMed ID: 6213200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antimicrobial spectrum of norfloxacin.
    Newsom SW
    J Antimicrob Chemother; 1984 May; 13 Suppl B():25-31. PubMed ID: 6234272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R; Allocati N; Catamo G
    Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The assessment of antimicrobial activity in an in-vitro model of the treatment of bacterial cystitis.
    Greenwood D
    J Antimicrob Chemother; 1984 May; 13 Suppl B():43-8. PubMed ID: 6234274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
    King A; Shannon K; Phillips I
    J Antimicrob Chemother; 1984 Apr; 13(4):325-31. PubMed ID: 6233249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottrad M; Stille W
    Eur J Clin Microbiol; 1983 Jun; 2(3):272-4. PubMed ID: 6224688
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
    Shungu DL; Weinberg E; Gadebusch HH
    Antimicrob Agents Chemother; 1983 Jan; 23(1):86-90. PubMed ID: 6219622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.
    Leigh DA; Smith EC; Marriner J
    J Antimicrob Chemother; 1984 May; 13 Suppl B():79-83. PubMed ID: 6234279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the emergence of resistance to lomefloxacin in vitro.
    Kanematsu M; Greenwood D
    Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):741-5. PubMed ID: 2506046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.